AHR and neoplasm: Activation of AHR signaling with tryptophan metabolites such as kynurenine (Kyn), an endogenous AHR ligand which is upregulated during inflammation and/or tumor progression, was shown to suppress the IFN-I response after infection with either RNA or DNA viruses (Yamada et al, 2016).